Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On February 8, 2026, The Nasdaq Stock Market LLC (“Nasdaq”) Office of General Counsel notified BioAtla, Inc. (the “Company”) that the Nasdaq Listi